Craig Fraser
CIK 1557420 · President and CEO · last filed 2024-10-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$124
Companies
3
Total Filings
57
Lifetime Open-Market Net
-$2.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 6 of 6
57 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-02-12 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | — | -$121.5K | EDGAR |
| 2014-01-06 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | — | -$130.7K | EDGAR |
| 2013-12-04 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | — | -$129.2K | EDGAR |
| 2013-11-05 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | — | -$158.0K | EDGAR |
| 2013-10-08 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | — | -$1.60M | EDGAR |
| 2013-04-03 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-09-06 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 51–57 of 57
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.